AA
DGX icon

Ancora Advisors’s Quest Diagnostics DGX Stock Holding History

Ancora Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Sell
137
-244
-64% -$47.9K ﹤0.01% 1217
2026
Q1 		$74.7K Hold
381
– – ﹤0.01% 1001
2025
Q4 		$66K Buy
381
+244
+178% +$44.4K ﹤0.01% 1049
2025
Q3 		$26.1K Hold
137
– – ﹤0.01% 1172
2025
Q2 		$24.5K Buy
137
+22
+19% +$3.82K ﹤0.01% 1183
2025
Q1 		$19.5K Buy
115
+2
+2% +$329 ﹤0.01% 1202
2024
Q4 		$17.1K Hold
113
– – ﹤0.01% 1247
2024
Q3 		$17.5K Buy
113
+2
+2% +$299 ﹤0.01% 1223
2024
Q2 		$15.2K Hold
111
– – ﹤0.01% 1217
2024
Q1 		$14.7K Buy
111
+1
+0.9% +$130 ﹤0.01% 1252
2023
Q4 		$15.2K Buy
110
+1
+0.9% +$131 ﹤0.01% 1210
2023
Q3 		$13.3K Hold
109
– – ﹤0.01% 1228
2023
Q2 		$15.3K Buy
109
+1
+0.9% +$138 ﹤0.01% 1189
2023
Q1 		$15.3K Hold
108
– – ﹤0.01% 1189
2022
Q4 		$17K Buy
108
+1
+0.9% +$144 ﹤0.01% 1220
2022
Q3 		$13K Hold
107
– – ﹤0.01% 1428
2022
Q2 		$14K Buy
107
+1
+0.9% +$136 ﹤0.01% 1515
2022
Q1 		$15K Hold
106
– – ﹤0.01% 1622
2021
Q4 		$18K Buy
106
+1
+1% +$152 ﹤0.01% 1618
2021
Q3 		$15K Hold
105
– – ﹤0.01% 1559
2021
Q2 		$14K Buy
105
+1
+1% +$131 ﹤0.01% 1441
2021
Q1 		$13K Hold
104
– – ﹤0.01% 1391
2020
Q4 		$12K Buy
+104
New +$12.7K ﹤0.01% 1159
2018
Q4 		– Sell
-375
Closed -$40K – 748
2018
Q3 		$40K Buy
+375
New +$41.1K ﹤0.01% 938
2017
Q1 		– Sell
-375
Closed -$34K – 711
2016
Q4 		$34K Buy
+375
New +$32.3K ﹤0.01% 838

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Ancora Advisors's DGX Position: Q2 2026 in Review

Ancora Advisors reduced its Quest Diagnostics (DGX) stake by 64% in Q2 2026, selling an estimated $47.9K and leaving 137 shares worth $29K. The position accounts for ﹤0.01% of the portfolio, ranked #1217.

Ancora Advisors first reported a position in DGX in Q4 2016 and has held it in 25 quarters since. The position peaked at $74.7K in Q1 2026. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Ancora Advisors held 137 shares of Quest Diagnostics worth $29K as of Q2 2026.
  • Ancora Advisors sold 244 Quest Diagnostics shares in Q2 2026, an estimated $47.9K.
  • Quest Diagnostics made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1217 holding.
  • Ancora Advisors first reported a position in Quest Diagnostics in Q4 2016 and has held it in 25 quarters since.
  • Ancora Advisors's Quest Diagnostics position peaked at $74.7K in Q1 2026.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.